We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Western Europe,Australasia,Asia
Monthly Production Capacity: 1000000kg
Contract Manufacturing: CRO
Packaging Information: 500g/bag , 1kg/bag, 10kg/drum , 20kg/drum or customized
Delivery Lead Time: 1
Sample Provided: yes
Payment Terms: TT
Hydroxypropyl Betadex oral grade USP Standard
Product Name: Hydroxypropyl Betadex
Synonyms: Hydroxypropyl Beta Cyclodextrin;
Hydroxypropyl-β-Cyclodextrin.
CAS#: 128446-35-5
EINECS: 420-920-1
DMF NO.: 030168
Quality: Pharmaceutical Grade
Standard: USP,EP,CP
Characteristics & Applications:
Hydroxypropyl Betadex Hydroxypropyl Beta Cyclodextrin can increase solubility and bioavailability of insoluble drugs, so that the efficacy of drugs can last longer with less ingestion of drugs. It can adjust and control drugs release ratio, decrease side effects of drugs, and enhance stability of drugs. Hydroxypropyl Beta Cyclodextrin can be used for oral medication, injection, mucosal delivery systems (including the nasal mucosa, rectum, cornea, etc. ), dermal drug delivery systems, lipophilic drugs targeting delivery, and also used as protective agent and stabilizer of protein.
Specifications:
CAS No
128446-35-5
Molecular Formula
C42H70-nO35(C3H8O2)n
Molecular Weight
1134.98+58n
Appearance
White or almost white, amorphous or crystalline powder. Freely soluble in water and in propylene glycol
Eight years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
